i Wajnrajch MP and New MI. Chapter 103: Defects of Adrenal Steroidogenesis. Endocrinology, Adult and Pediatric. 6th Edition. 2010. pp 1897-1920.
ii Pang SY, Wallace MA, Hofman L, et al. 1988 Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81:866-74
iii NNSIS 2009 National Newborn Screening Information System. Available at http://www2.uthscsa.edu/nnsis
iv Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI 1985 High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37:650-67
v Sherman SL, Aston CE, Morton NE, Speiser P, New MI 1988 A segregation and linkage study of classical and nonclassical 21-hydroxylase deficiency. Am J Hum Genet 42:830-838
vi Zerah M, Ueshiba H, Wood E, et al. 1990 Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study. Journal of Clinical Endocrinology & Metabolism 70:1662-7
vii Zachmann M, Tassinari D, Prader A 1983 Clinical and biochemical variability of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. J Endocrinol Metab 56:222-229
viii Curnow KM, Slutsker L, Vitek J, et al. 1993 Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci (USA) 90:4552
ix Khemiri M, Ridane H, Bou YO, Matoussi N, Khaldi F 2006. 11 beta hydroxylase deficiency: a clinical study of seven cases. Tunis Med 84:106-13
x Rosler A, Leiberman E, Cohen T 1992 High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. Am J Med Genet 42:827-34
xi Paperna T, Gershoni-Baruch R, Badarneh K, Kasinetz L, Hochberg Z 2005 Mutations in CYP11B1 and congenital adrenal hyperplasia in Moroccan Jews. J Clin Endocrinol Metab 90:5463-5
xii Ganong W 1963 The central nervous system and the synthesis and release of adrenocorticotrophic hormone. In: Nalbandov A (ed) Advances in Neuroendocrinology. University of Illinois Press, Urbana, p 92
xiii Guillemin R, Schally A 1963 Recent advances in the chemistry of neuroendocrine mediators originating in the central nervous system. In: Nalbandov A (ed) Advances in Neuroendocrinology. University of Illinois Press, Urbana, p 314
xiv Goto M, Piper Hanley K, Marcos J, et al. 2006 In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest 116:953-60
xv Prader A, Gurtner HP 1955 The syndrome of male pseudohermaphrodism in congenital adrenocortical hyperplasia without overproduction of androgens (adrenal male pseudohermaphrodism). Helv Paediatr Acta 10:397-412
xvi DiMartino-Nardi J, Stoner E, O'Connell A, New MI. The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH). Acta Endocrinol Suppl (Copenh). 1986;279:305-14.
xvii New MI, Gertner JM, Speiser PW et al. Growth and final height in classical and nonclassical 21-hydroxylase deficiency. J Endocrinol Invest. 1989;12(8 Suppl 3):91-5.
xviii Lin-Su K, Vogiatzi MG, Marshall I, et al. 2005 Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 90:3318-25
xix Quintos JB, Vogiatzi MG, Harbison MD, New MI 2001 Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:1511-7
xx Trinh L, Nimkarn S, Obeid J, New M, Su K Growth and Pubertal Characteristics in Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. J Pediatr Endocrinol Metab. 2007 Aug;20(8):883-91.
xxi Klingensmith G, Garcia S, Jones H, Migeon C, Blizzard R 1977 Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility. J Pediatr 90:996-1004
xxii Helleday J, Siwers B, Ritzen EM, Carlstrom K. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J Clin Endocrinol Metab 1993;76(4):933-6.
xxiii Premawardhana L, Hughes I, Read G, Scanlon M. Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin Endocrinol (Oxf) 1997;46(3):327-32.
xxiv Richards G, Grumbach M, Kaplan S, Conte F. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. J Clin Endocrinol Metab 1978;47(6): pp 1208-15.
xxv Barnes R, Rosenfield R. and Ehrmann D. et al., Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women, J Clin Endocrinol Metab 79 (1994), pp. 1328�1333.
xxvi Long D., Wisniewski A. and Migeon C. Gender role across development in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Pediatr Endocrinol Metab 17 (2004), pp. 1367�1373.
xxvii Hines M., Brook C and Conway G. Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH), J Sex Res 41 (2004), pp. 75�81.
xxviii Meyer-Bahlburg H., Dolezal C. and Baker S. et al., Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess, Arch Sex Behav 37 (2008), pp. 85�99.
xxix Berenbaum S. Cognitive Function in Congenital Adrenal Hyperplasia. Endocrinol Metab Clinic North America. 2001. Mar;30(1):173-92
xxx Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. NEJM 1987;316:178-82.
xxxi Cabrera M, Vogiatzi M, New M 2001 Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:3070-3080
xxxii Bonaccorsi A, Adler I, Figueiredo J 1987 Male infertility due to congenital adrenal hyperplasia: testicular biopsy findings, hormonal evaluation, and therapeutic results in three patients. Fertil Steril 47: pp 664-70
xxxiii Prader A: Vollkommen mannliche aussere Genitalentwicklung und Salzerlutsyndrom bei Madech mit Kongenitalem Androgenitalem Syndrom. Helv Paediatr Act 13:5-14, 1958.
xxxiv Urban M, Lee P, Migeon C 1978 Adult height and fertility in men with congenital virilizing adrenal hyperplasia. New Engl J Med 299:1392
xxxv Claahsen-van der Grinten HL, Sweep FC, Blickman JG, Hermus AR, Otten BJ 2007 Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol 157:339-44
xxxvi Molitor J, Chertow B, Fariss B 1973 Long-term follow-up of a patient with congenital adrenal hyperplasia and failure of testicular development. Fertil Steril 24:319
xxxvii Claahsen-van der Grinten HL, Otten BJ, Hermus AR, Sweep FC, Hulsbergen-van de Kaa CA 2008 Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia can cause severe testicular damage. Fertil Steril 89:597-601
xxxviii Wilkins L, Crigler J, Silverman S, Gardner L, Migeon C 1952 Further studies on the treatment of congenital adrenal hyperplasia with cortisone. II. The effects of cortisone on sexual and somatic development, with an hypothesis concerning the mechanism of feminization. J Clin Endocrinol Metab 12:277
xxxix Blumberg-Tick J, Boudou P, Nahoul K, Schaison G 1991 Testicular tumors in congenital adrenal hyperplasia: steroid measurements from adrenal and spermatic veins. J Clin Endocrinol Metab 73:1129-33
xl Schoen E, DiRaimondo V, Dominguez O 1961 Bilateral testicular tumors complicating congenital adrenocortical hyperplasia. J Clin Endocrinol Metab 21:518
xli Miller E, Murray H 1962 Congenital adrenocortical hyperplasia: case previously reported as "bilateral interstitial cell tumor of the testicle�. J Clin Endocrinol Metab 22:655
xlii Glenn J, Boyce W 1963 Adrenogenitalism with testicular adrenal rests simulating interstitial cell tumor. J Urol 89:456
xliii Srikanth M, West B, Ishitani M, Isaacs HJ, Applebaum H, Costin G 1992 Benign testicular tumors in children with congenital adrenal hyperplasia. J Pediatr Surg 27:639-41
xliv Rutgers J, Young R, Scully R 1988 The testicular "tumor" of the adrenogenital syndrome. A report of six cases and review of the literature on testicular masses in patients with adrenocortical disorders. Am J Surg Pathol 12:503-13
xlv Sugino Y, Usui T, Okubo K, et al. 2006 Genotyping of congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as male infertility: case report and literature review. J Assist Reprod Genet 23:377-80
xlvi Klein R 1960 Evidence for and evidence against the existence of a salt-losing hormone. J Pediatr 57:452
xlvii Kowarski A, Finkelstein JW, Spaulding JS, Holman GH, Migeon CJ 1965 Aldosterone Secretion Rate in Congenital Adrenal Hyperplasia. A Discussion of the Theories on the Pathogenesis of the Salt-Losing Form of the Syndrome. J Clin Invest 44:1505-13
xlviii Kuhnle U, Land M, Ulick S 1986 Evidence for the secretion of an antimineralocorticoid in congenital adrenal hyperplasia. J Clin Endocrinol Metab 62:934-40
xlix Tusie-Luna M, Traktman P, White PC: Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Bio Chem 265:20916-20922, 1990.
l Stoner E, Dimartino-Nardi J, Kuhnle U, Levine LS, Oberfield SE, New MI 1986 Is salt-wasting in congenital adrenal hyperplasia due to the same gene as the fasciculata defect? Clin Endocrinol (Oxf) 24:9-20
li Luetscher JA 1956 Studies of aldosterone in relation to water and electrolyte balance in man. Recent Prog Horm Res 12:175
lii Speiser PW, Agdere L, Ueshiba H, White PC, New MI 1991 Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase. New England Journal of Medicine 324:145-9
liii Rose L, Newmark S, Strauss J, Pochi P. Adrenocortical hydroxylase deficiencies in acne vulgaris. J Invest Dermatol 1976;66(5): pp 324-6.
liv Lucky A, Rosenfield R, McGuire J, Rudy S, Helke J. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab 1986;62(5): pp 840-8.
lv Lin-Su, K, Nimkarn S, New MI. Congenital adrenal hyperplasia in adolescence: diagnosis and management. Ann NY Acad Sci. 2008;1135:95-8.
lvi Witchel SF and Azziz R. Nonclassic Congenital Adrenal Hyperplasia. International Journal of Pediatric Endocrinology. Volume 2010. pp 1-11.
lvii Mokshagundam S, Surks M 1993 Congenital adrenal hyperplasia diagnosed in a man during workup for bilateral adrenal masses. Arch Intern Med 153:1389-91
lviii Jaresch S, Kornely E, Kley H, Schlaghecke R 1992 Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab 74:685-9
lix Barzon L, Scaroni C, Sonino N et al. Incidentally discovered adrenal tumors: endocrine and scintographic correlates. 1998 J Clin Endocrinol Metab 74:685-689.
lx Nieman L. Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metab, September 2010, 95(9):4106-4113.
lxi Nimkarn S, New MI 2008 Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia. Trends Endocrinol Metab 19:96-9
lxii Mimouni M, Kaufman H, Roitman A, Morag C, Sadan N 1985 Hypertension in a neonate with 11 beta-hydroxylase deficiency. Eur J Pediatr 143:231-3
lxiii Globerman H, Rosler A, Theodor R et al. An inherited defect in aldosterone biosynthesis caused by a mutation in or near the gene for steroid 11-hydroxylase. N Engl J Med 319:1193-1197, 1988.
lxiv Rosler A, Leiberman E, Sack J 1982 Clinical variability of congenital adrenal hyperplaisa due to 11B-hydroxylase deficiency. Hormone Research 16:133
lxv Hague WM, Honour JW 1983 Malignant hypertension in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Clin Endocrinol (Oxf) 18:505-10
lxvi Chabre O, Portrat-Doyen S, Chaffanjon P, et al. 2000 Bilateral laparoscopic adrenalectomy for congenital adrenal hyperplasia with severe hypertension, resulting from two novel mutations in splice donor sites of CYP11B1. J Clin Endocrinol Metab 85:4060-8
lxvii Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency, J. Clin. Endocrinol. Metab. 56 (1983), pp. 222�229.
lxviii Joehrer K, Geley S, Strasser-Wozac E et al. CYP11B1 Mutations Causing Non-Classic Adrenal Hyperplasia due to 11β-Hydroxylase Deficiency. Hum. Mol. Genet. (1997) 6 (11): 1829-1834.
lxix Peters CJ, Tugent T, Perry LA et al. Cosegregation of a Novel Homozygous CYP11B1 Mutation with the Phenotype of Non-Classical Congenital Adrenal Hyperplasia in a Consanguious Family, Horm. Res. 67 (2007), pp. 189�193
lxx Simard J, Rheaume E, Mebarki F et al. Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency. J Steroid Biochjem Mol Biol. 1995 Jun;53(1-6):127-38
lxxi Labrie F, Simard J, Luu-The V, et al. 1992 Structure and tissue-specific expression of 3 beta-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase genes in human and rat classical and peripheral steroidogenic tissues. J Steroid Biochem Mol Biol 41:421-35
lxxii Pang S. Congenital adrenal hyperplasia owing to 3 beta-hydroxysteroid dehydrogenase deficiency. Endocrinol Metab Clin North Am. 2001 Mar;30(1):81-99, vi-vii.
lxxiii Yanase T, Simpson E, Waterman M 1991 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12:91-108
lxxiv Miller W, Auchus R and Geller D. The regulation of 17, 20 lyase activity. Steroids, Volume 62, Issue 1, January 1997, Pages 133-142
lxxv Bose H, Sugawara T, Strauss Jr, Miller W 1996 The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N Engl J Med 335: 1870-8
lxxvi Bose HS, Sato S, Aisenberg J, Shalev SA, Matsuo N, Miller WL. Mutations in the Steroidogenic Acute Regulatory Protein (StAR) in Six Patients with Congenital Lipoid Adrenal Hyperplasia. J Clin Endocrinol Metab. 2000 Oct;85(10):3636-9.
lxxvii Miller WL. Mechanism of StAR�s regulation of mitochondrial cholesterol import. Molecular and Cellular Endocrinology 265-266 (2007), pp 46-50.
lxxviii Stocco D, Clark B 1997 The role of the steroidogenic acute regulatory protein in steroidogenesis. Steroids 62:29-36
lxxix Sahakitrungruang T, Soccio R, Lang-Muritano M, et al. Clinical, genetic and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR). J Clin Endocrin Metab, July 2010, 95(7), pp 1-7.
lxxx Scott RR, Miller WL. Genetic and clinical features of P450 oxidoreductase deficiency. Hor Res. 2008;69(5). Pp. 266-75.
lxxxi Fluck CE, Pandey AV, Huang N et al. P450 oxidoreductase deficiency � a new form of congenital adrenal hyperplasia. Endocr Dev. 2008; 13:67-81. Review.
lxxxii Fluck CE, Tajima T, Pandey AV, et al. 2004 Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36:228-30
lxxxiii Wilson RC, Mercado AB, Cheng KC, New MI 1995 Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80:2322-2329
lxxxiv Nimkarn S, Cerame BI, Wei JQ, et al. 1999 Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations. J Clin Endocrinol Metab 84:378-81
lxxxv Tajima T, Fujieda K, Kouda N, Nakae J, Miller W 2001 Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 86: 3820-3825
lxxxvi Nebert DW, Nelson DR, Coon MJ. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol 1991;10:1-14.
lxxxvii Dupont B, Oberfield SE, Smithwick EM, Lee TD, Levine LS. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet 1977;2(8052-8053):1309-12.
lxxxviii White PC, Grossberger D, Onufer BJ, et al. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci U S A 1985;82(4):1089-93.
lxxxix Carroll MC, Campbell RD, Porter RR. The mapping of 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci USA 1985;82:521-5.
xc Belt KT, Carroll MC, Porter RR. The structural basis of the multiple forms of human complement component C4. Cell 1984;36(4):907-14.
xci White PC, New MI, Dupont B. Structure of the human steroid 21-hydroxylase genes. Proc Natl Acad Sci U S A 1986;83(14):5111-5.
xcii Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci U S A 1986;83(9): p2841-5.
xciii Human Gene Mutation Database (HGMD): 2010 update.
xciv Werkmeister JW, New MI, Dupont B, White PC. Frequent deletion and duplication of the steroid 21-hydroxylase genes. Am J Hum Genet. 1986 Oct;39(4):461-9.
xcv Finkielstain GP, Chen W, Mehta SP et al. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2010 Oct 6 [Epub ahead of print].
xcvi Krone N, Braun A, Roscher A, Knorr D, Schwarz H. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 2000;85(3): p1059-65.
xcvii Rocha RO, Billerbeck AE, Pinto EM et al. The degree of external genitalia virilization in girls with 21-hydroxylase deficiency appears to be influenced by the CAG repeats in the androgen receptor gene. Clin Endocrinol (Oxf). 2008 Feb;68(2):226-32.
xcviii Forest MG. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update. 2004 Nov-Dec;10(6):469-85.
xcix Pang S, Levine LS, Chow DM, Faiman C, New MI 1979 Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 11:575-84
c Korth-Schutz S, Virdis R, Saenger P, Chow DM, Levine LS, New MI 1978 Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab 46:452-8
ci Caulfield MP, Lynn T, Gottschalk ME, et al. 2002 The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J Clin Endocrinol Metab 87:3682-90
cii Shackleton CH. Profiling steroid hormones and urinary steroids. J Chromatogr. 1986 Jun 20;379:91-156. Review
ciii Pang S, Hotchkiss J, Drash AL, Levine LS, New MI 1977 Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 45:1003-8
civ Speiser P, Azziz R, Baskin L, et al. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, September 2010, 95(9):4133�4160
cv Gruneiro-Papendieck L, Prieto L, Chiesa A, Bengolea S, Bossi G, Bergada C 2001 Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol. Horm Res 55:271-7
cvii New MI, Lorenzen F, Lerner AJ, et al. 1983 Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 57:320-6
cviii Jeffcoate T, Fleigner J, Russell S, Davis J, Wade A 1965 Diagnosis of the adrenogenital syndrome before birth. Lancet 2:553
cix Wilson RC, Wei J-Q, Cheng KC et al. Rapid deoxyribonucleic acid analysis by allele specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J Clin Endocrinol Metab 80: 1635-1640, 1995.
cx Tukel T, Uyguner O, Wei J, et al. 2003 A Novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency. J Clin Endocrinol Metab 88:5893-5897
cxi Mao R, Nelson L, Kates R, et al. 2002 Prenatal diagnosis of 21-hydroxylase deficiency caused by gene conversion and rearrangements: pitfalls and molecular diagnostic solutions. Prenat Diagn 22:1171-6
cxii Day DJ, Speiser PW, Schulze E, et al. 1996 Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet 5:2039-48
cxiii 2000 Technical report: congenital adrenal hyperplasia. Section on Endocrinology and Committee on Genetics. Pediatrics 106:1511-8
cxiv Lo D, Corbetta N, Chamberlain P et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-87.
cxv Bischoff FZ, Nguyen DD, Marquez Do D, Moise KJ Jr, Simpson JL, Elias S.
Noninvasive Determination of fetal RhD Statues Using Fetal DNA in Maternal Serum
and PCR. J Soc Gynecol Invest 199;6: 64-69. 1999.
cxvi Lo YM, Lau TK, Zhang J, Leung TN, Chang AM, Hjelm NM, Elmes RS, Bianchi DW.
Increased Fetal DNA concentrations in the plasma of pregnant women carrying fetuses
with Trisomy 21. Clin Chem 45, 1747-1751. 1999.
cxvii Farina A, LeShane ES, Lambert-Messerlian GM, Canick JA, Lee T, Neveux LM,
Palomaki GE, Bianchi DW. Evaluation of cell-free fetal DNA as a second-trimester
maternal serum marker of Down syndrome pregnancy. Clin Chem 49,239-242. 2003.
cxviii Johnson KL, Dukes KA, Vidaver J, LeShane ES, Ramirez I, Weber WD, Bischoff FZ,
Hahn S, Sharma A, Dang DX, Hire LM, Bianchi DW, Simpson JL, Holzgreve W, Elias S,
and Klinger KW. Interlaboratory comparison of fetal male DNA detection from common
maternal plasma samples by real time PCR. Clin Chem. 50 2004 516-21.
cxix Bischoff FZ, Lewis DE, and Simpson JL. Cell-free fetal DNA in maternal blood:
kinetics, source and structure. Hum Reprod Update.11 2005 59-67.
cxx Chiu RW, Lau TK, Cheung PT et al. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem. 48 2002 778-80.
cxxi Simpson JL. Preimplantation genetic diagnosis at 20 years. Prenat Diagn. 2010 Jul;30(7):682-95.
cxxii Fiorentino F, Biricik A, Nuccitelli A, et al. 2006 Strategies and clinical outcome of 250 cycles of Preimplantation Genetic Diagnosis for single gene disorders. Hum Reprod 21:670-84
cxxiii David M, Forest MG 1984 Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 105:799-803
cxxiv New MI, Carlson A, Obeid J et al. 2001 Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 86:5651-5657.
cxxv Forest MG, David M and Morel Y (1993) Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 45, 75�82.
cxxvi Mercado AB, Wilson RC, Cheng KC, Wei JQ, New MI 1995 Extensive personal experience: Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 80:2014-2020
cxxvii Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):19-29. Review.
cxxviii Saenger P 1984 Abnormal sex differentiation. J Pediatr 104:1-17
cxxix Meyer-Bahlburg HFL, Dolezal C, Baker SW, Ehrhardt AA, New MI 2006 Gender development in women with congenital adrenal hyperplasia as a function of disorder severity. Archives of Sexual Behavior 35:667-684
cxxx American Journal of Bioethics. 10(9). Multiple articles in issue devoted to the subject
cxxxi Seckl JR 2004 Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 151 Suppl 3:U49-62
cxxxii Seckl JR, Miller WL 1997 How safe is long-term prenatal glucocorticoid treatment? JAMA 277:1077-9
cxxxiii Yeh TF, Lin YJ, Lin HC, et al. 2004 Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350:1304-13
cxxxiv Slotkin TA, Zhang J, McCook EC, Seidler FJ 1998 Glucocorticoid administration alters nuclear transcription factors in fetal rat brain: implications for the use of antenatal steroids. Brain Res Dev Brain Res 111:11-24
cxxxv Uno H, Lohmiller L, Thieme C, et al. 1990 Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res 53:157-67
cxxxvi Hirvikoski T, Nordenstr m A, Lindholm T et al. 2007 Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab 92:542-548.
cxxxvii Hirvikoski T, Nordenstr m A, Lindholm T et al. 2008 Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia : does dexamethasone cause behavioral problems ? Eur J Endocrinol 159:309-316.
cxxxviii Meyer-Bahlburg H, Dolezal C, Haggerty R et al. Cognitive and educational outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Submitted for publication.
cxxxix New M, Carlson A, Obeid J, et al. 2003 Update: Prenatal diagnosis for congenital adrenal hyperplasia in 595 pregnancies. The Endocrinologist 13:233-239
cxl Forest MG, Dorr HG 2003 Prenatal therapy in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Retrospective follow-up study of 253 treated pregnancies in 215 families. Endocrinologist 13:252-259
cxli Trautman PD, Meyer-Bahlburg HFL, Postelnek J, New MI 1996 Mothers' reactions to prenatal diagnostic procedures and dexamethasone treatment of CAH. J Psycho Obst Gyn 17:175-81
cxlii Lajic S, Nordenstrom A, Ritzen EM, Wedell A 2004 Prenatal treatment of congenital adrenal hyperplasia. Eur J Endocrinol 151 Suppl 3:U63-9
cxliii Lajic S, Wedell A, Bui T, Ritzen E, Holst M 1998 Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 83:3872-80
cxliv Goldman A, Sharpior B, Katsumata M 1978 Human foetal palatal corticoid receptors and teratogens for cleft palate. Nature 272:464-6
cxlv Nandi J, Bern HA, Biglieri EG, Pieprzyk JK 1967 In vitro steroidogenesis by the adrenal glands of mice. Endocrinology 80:576-82
cxlvi New MI. Long Range Outcome of Prenatal Treatment. Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology. 2nd World Conference. Miami, FL. January 2010.
cxlvii Rosler A, Leiberman E, Rosenmann A 1979 Prenatal diagnosis of 11beta hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 49:546
cxlviii Schumert Z, Rosenmann A, Landau H, Rosler A 1980 11-Deoxycortisol in amniotic fluid: Prenatal diagnosis of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Clin Endocrinol 12:257
cxlix Sippell WG, Muller-Holve W, Dorr HG, Bidlingmaier F, Knorr D 1981 Concentrations of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol, and cortisone determined simultaneously in human amniotic fluid throughout gestation. J Clin Endocrinol Metab 52:385-92
cl Cerame BI, Newfield RS, Pascoe L, et al. 1999 Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia. J Clin Endocrinol Metab 84:3129-34
cli Geley S, Kapelari K, Johrer K, et al. 1996 CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab 81:2896-901
clii Motaghedi R, Betensky BP, Slowinska B, et al. 2005 Update on the prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. J Pediatr Endocrinol Metab 18:133-42
cliii Nimkarn S, Lin-Su K, Berglind N, Wilson RC, New MI 2006 Aldosterone-to-Renin Ratio as a Marker for Disease Severity in 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab
cliv Rosler A, Levine LS, Schneider B et al. The interrelationship of Sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. Journal of Clin Endoc and Metab, Spt 1977, Vol. 45, No. 3, pp 500-512.
clv New MI and Seaman MP. Secretion rates of cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 30 (1970), pp. 361�371.
clvi Canalis E 1996 Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocirnol Metab 81:3441-7
clvii Canalis E, Bilezikian JP, Angeli A, Giustina A 2004 Perspectives on glucocorticoid-induced osteoporosis. Bone 34:593-8
clviii Mazziotti G AA, Bilezikian JP, Canalis E, Giustina A 2006 Glucocorticoid-induced osteoporosis: an update. Trend Endocrinol Metab 17:144-9
clix Cameron F, Kaymakci B, Byrt E, Ebeling P, Warne G, Wark J 1995 Bone mineral density and body composition in congenital adrenal hyperplasia. J Clin Endocrinol Metab 80:2238-43
clx Guo C, Weetman A, Eastell R 1996 Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 45:535-41
clxi de Almeida Freire PO, de Lemos-Marini SH, Maciel-Guerra AT, et al. 2003 Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density. J Bone Miner Metab 21:396-401
clxii King JA, Wisniewski AB, Bankowski BJ, Carson KA, Zacur HA, Migeon CJ 2006 Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 91:865-9
clxiii Lin-Su K and New MI. Effects of adrenal steroids on the bone metabolism of children with congenital adrenal hyperplasia. Ann N Y Acad Sci. 2007 Nov;1117:345-51.
clxiv Crouch NS, Liao LM, Woodhouse CR, Conway GS, Creighton SM. Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia. J Urol. 2008 Feb;179(2):634-8. Epub 2007 Dec 21
clxv Nordenstrom A, Frisen L, Falhammar H et al. Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency : clinical perspective and the patients� perception. J Clin Endocrinol Metab 95: 3633-3640, 2010.
clxvi VanWyk JJ, Gunther DF, Ritzen M et al. The use od adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab 81: 3180-3182, 1996.
clxvii Gmyrek G, New M, Sosa R, Poppas D 2002 Bilateral laparoscopic adrenalectomy as a treatment for classic congenital adrenal hyperplasia attributable to 21-hydroxylase deficiency. Pediatrics 109: pE28